Skip to main content
. 2023 Jan 30;18(6):736–744. doi: 10.1177/17474930231153313

Figure 3.

Figure 3.

Twelve-month mean CVR changes in candesartan (green) versus placebo (blue) for whole brain (A), frontal (B), parietal (C), temporal (D) lobes, and hippocampus (E)—results from CEDAR trial only. p-values correspond to between-group differences (visit × group), calculated from mixed-model repeated measures of CVR over the study period. Error bars are standard errors. Change in ETCO2 during CO2 exposure and sitting systolic blood pressure were included as covariates in all repeated measure models.